@Jinsun, I was only 1-week into my Ipamorelin/CJC when these bloods were done, hence the minimal initial impact on my IGF-1 level
Our findings highlight the beneficial effects of GLP-1 RAs in improving survival and reducing adverse cardiac and kidney events in individuals with type 2 diabetes and AKD
In early 2026, Canada may become the first major Western jurisdiction to allow generic semaglutide, ahead of the United States and Europe
Commonly reported side effects include: Nausea and vomiting Diarrhea or constipation Decreased appetite In some cases, more serious health concerns have been reported, including: Gastroparesis (Stomach Paralysis) A condition where the stomach empties food very slowly or stops functioning properly, potentially causing severe nausea, vomiting, bloating, abdominal pain, and difficulty eating
Consistent with this, we observed gain or increased dosage of numerous mutated genes in metastatic tumours in transition from diploid to hyperploid states
consistency and progressive overload matter more than session length